Sponsors (9)
The bill significantly expands parental control and protects providers and taxpayers by restricting federal support for sex‑trait altering treatments for minors, but at the cost of substantially reduced access to care for transgender youth, major financial and legal pressure on health systems and providers, and increased litigation and federal‑state conflict.
Parents and guardians (and families) gain clear written-notice and consent/ refusal rights over minors' sex‑trait altering treatments, increasing parental control of those medical decisions.
Federal funding for sex‑trait altering treatments for minors is blocked, preventing taxpayer dollars from financing those services and creating enforcement mechanisms to hold agencies accountable.
Health care providers, institutions, insurers, and plans are protected from penalties or discrimination for refusing to perform, facilitate, or cover sex‑trait altering treatments, and can seek civil relief if penalized.
Transgender and gender‑diverse minors (and some adults receiving non‑genital procedures) face substantially reduced access to gender‑affirming medical care, risking worse mental‑health outcomes and interruptions of medically recommended treatment.
Hospitals, clinics, community and rural health centers, and medical schools risk losing federal grants, research and training funds, program participation (Medicaid/Medicare), and patients—potentially forcing service reductions, clinic closures, and job losses that harm access for many communities.
The bill creates large new civil‑liability risks for providers (treble damages, attorney fees, and very long statutes of limitation), likely raising malpractice exposure, insurance costs, and prompting defensive medicine or provider withdrawal from adolescent care.
Based on analysis of 11 sections of legislative text.
Blocks federal funds and requires parental consent before medical/surgical gender‑affirming treatments for minors, creates broad private lawsuits and provider conscience protections.
Introduced March 26, 2025 by Robert F. Onder · Last progress March 26, 2025
Prohibits federal funds from supporting gender‑affirming medical or surgical treatments for people under 18 and conditions federal funding for schools, states, and health programs on parental notice and written consent before such treatments. The bill defines “sex‑trait altering treatment” (including puberty blockers, cross‑sex hormones, and many surgeries), lists limited medical exceptions, and bars federal agencies, medical institutions, and schools from paying for, promoting, or facilitating these treatments for minors. Creates multiple private rights of action allowing individuals (including taxpayers, parents, minors, and providers) to sue federal agencies, states, institutions, or individual providers for violations; imposes pre‑treatment parental consultation and consent requirements; expands civil liability (including treble damages and fee awards) for harms from treatments performed on minors; and forbids penalties against providers who decline to provide or refer for such treatments.